Imagion Biosystems teams with Planet Innovation for MagSense™ instrument development
MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, and Planet Innovation, a healthtech innovation and commercialization company, are pleased to announce that they have entered into a…
Read MoreVictoria leads the way with NHMRC funding
13 December 2018 The announcement of the latest round of NHMRC funding yesterday has again highlighted the strength of Melbourne’s medical research community. Continuing the state’s unbroken record of receiving more than 40% of NHMRC competitive grant funding,…
Read MoreDesign + Industry is now ISO 13485:2016 certified
BioMelbourne Network member Design + Industry (D+I) is proud to announce that they have achieved ISO 13485:2016 certification — the culmination of a four-year effort and recognition of their commitment to design and engineering excellence in the development…
Read MoreBoard announcement: CEO resignation
6 December 2018 Message from the Chair On behalf of the Board of BioMelbourne Network, I advise our Members, partners and associates that our CEO, Dr Krystal Evans, has tendered her resignation. Krystal will leave us in the…
Read More2019 ARCS Annual Conference: call for session and program proposals extended
Interested parties from industry, research institutions, government and academia involved in development through to commercialisation of therapeutics (from bench to bedside) are invited to submit session proposals and program suggestions for the 2019 ARCS Annual Conference to be…
Read MoreBioEYES looking for industry partners
3 December 2018 BioEYES Australia is a science outreach program that covers curricula in genetics, cell biology and developmental biology, but more importantly excites students about the thrill of scientific discovery. Over a 1 week incursion, students set…
Read More
